Inclisiran: First Approval.
Lamb YN.
Drugs. 2021 Feb;81(3):389-395. doi: 10.1007/s40265-021-01473-6.
Addressing the underdiagnosis of familial hypercholesterolemia: A mixed methods study exploring the knowledge and practice behaviors of cardiology healthcare providers.
Kalia I, Shope R, Reilly M, Schwartz L.
J Clin Transl Sci. 2023 Apr 5;7(1):e92. doi: 10.1017/cts.2023.519. eCollection 2023.
Ezetimibe.
Sizar O, Nassereddin A, Talati R.
2023 Aug 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Rosuvastatin.
Bajaj T, Giwa AO.
2023 May 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Tafolecimab: First Approval.
Keam SJ.
Drugs. 2023 Nov;83(16):1545-1549. doi: 10.1007/s40265-023-01952-y.
Familial Hypercholesterolemia Prevalence Among Ethnicities-Systematic Review and Meta-Analysis.
Toft-Nielsen F, Emanuelsson F, Benn M.
Front Genet. 2022 Feb 3;13:840797. doi: 10.3389/fgene.2022.840797. eCollection 2022.
Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
Ramli AS, Qureshi N, Abdul-Hamid H, Kamal A, Kanchau JD, Shahuri NS, Akyea RK, Silva L, Condon L, Abdul-Razak S, Al-Khateeb A, Chua YA, Mohamed-Yassin MS, Baharudin N, Badlishah-Sham SF, Abdul Aziz AF, Mohd Kasim NA, Sheikh Abdul Kadir SH, Kai J, Leonardi-Bee J, Nawawi H.
JMIR Res Protoc. 2023 Jun 2;12:e47911. doi: 10.2196/47911.
Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia.
Pedro-Botet J, Climent E, Gabarró N, Millán J.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:43-49. doi: 10.1016/j.arteri.2020.12.013.
Recaticimab: First Approval.
Lamb YN.
Drugs. 2025 Aug;85(8):1067-1072. doi: 10.1007/s40265-025-02199-5. Epub 2025 Jun 23.
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab.
Zhang Y, Pei Z, Chen B, Qu Y, Dong X, Yu B, Wang G, Xu F, Lu D, He Z, Chen B, Ma L, Wang M, Li B, Xia M, Zheng B, Huo Y.
Pharmacol Res. 2024 Sep;207:107340. doi: 10.1016/j.phrs.2024.107340. Epub 2024 Aug 5.
